AUPH Earnings

Quarterly EPS
$0.10
Q3 2024
$0.01
Q4 2024
$0.17
Q1 2025
$0.16
Q2 2025
$0.24
Q3 2025
$1.60
Q4 2025
$0.26
Q1 2026
$0.29
Q2 2026
Latest Revenue83.2M
Latest Net Income37.4M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.2983.2M37.4M+18.9%+81.2%
Q1 2026$0.2677.7M34.4M+24.4%+52.9%
Q4 2025$1.6077.1M210.8M+28.8%+15,900.0%
Q3 2025$0.2473.5M31.6M+8.4%+140.0%
Q2 2025$0.1670.0M21.5M+22.4%+1,500.0%
Q1 2025$0.1762.5M23.3M+24.2%+342.9%
Q4 2024$0.0159.9M1.4M+32.8%+105.3%
Q3 2024$0.1067.8M14.3M+24.3%+211.1%
Q2 2024$0.0157.2M722.0K
Q1 2024-$0.0750.3M-10749000
Q4 2023-$0.1945.1M-26875000
Q3 2023-$0.0954.5M-13447000
Aurinia Pharmaceuticals (AUPH) — Earnings